Curiosities in drug metabolism

References

• Ahmad F, Kaphalia BS, Khan MF, Ansari GAS. (1993). Fatty acid anilides: a new conjugation pathway of aniline. Biochem Arch 9:111–18
   Google Scholar
• Ansara GAS, Bhupendra S, Kaphalia M, Firoze Khan M. (1995). Fatty acid conjugates of xenobiotics. Toxicol Rev 75:1–17
   Google Scholar
• Aqúndez JA, Martinez C, Benitez J. (1995). Metabolism of aminopyrine and derivatives in man: in vivo study of monomorphic and polymorphic metabolic pathways. Xenobiotica 25:417–27
   PubMedGoogle Scholar
• Aycock RD, Kass DA. (2012). Abnormal urine color. South Med J 105:43–7
   PubMedGoogle Scholar
• Bachman GB, Hass HB, Platau GO. (1954). Derivatives of α,α-dimethylphenylethylamine. J Am Chem Soc 76:3972–74
   Google Scholar
• Bachmann C, Bickel MH. (1985–86). History of drug metabolism: the first half of the 20th century. Drug Metab Rev 16:185–253
   PubMed Web of Science ®Google Scholar
• Beckett AH. (1977). Metabolic oxidation of nitrogen and adjacent carbon atoms. In: Parke DV, Smith RL, eds. Drug metabolism – from microbe to man. London: Taylor and Francis Ltd., 33–42
   Google Scholar
• Beckett AH, Bélanger PM. (1974a). The identification of three new metabolic products of phentermine after liver microsomal incubations. Xenobiotica 4:509–19
   PubMed Web of Science ®Google Scholar
• Beckett AH, Bélanger PM. (1974b). Metabolism of chlorphentermine and phentermine in man to yield hydroxylamino, C-nitroso-, and nitrocompounds. J Pharm Pharmacol 26:205–6
   PubMed Web of Science ®Google Scholar
• Beckett AH, Bélanger PM. (1975). Identification and analysis of the metabolic products of mephentermine. J Pharm Pharmacol 27:928–36
   PubMed Web of Science ®Google Scholar
• Beckett AH, Bélanger PM. (1976). The microsomal N-oxidation of phentermine. J Pharm Pharmacol 28:692–9
   PubMed Web of Science ®Google Scholar
• Beckett AH, Bélanger PM. (1977a). The metabolism, distribution and elimination of chlorphentermine in man. Br J Clin Pharmacol 4:193–200
   PubMedGoogle Scholar
• Beckett AH, Bélanger PM. (1977b). The in vitro metabolism of mephentermine. Biochem Pharmacol 26:1455–62
   PubMedGoogle Scholar
• Beckett AH, Bélanger PM. (1978). The disposition of phentermine and its N-oxidised products in the rabbit. Xenobiotica 8:55–60
   PubMed Web of Science ®Google Scholar
• Beckett AH, Brookes LG. (1971). The metabolism and urinary excretion in man of phentermine and the influence of N-methyl and p-chloro substitutions. J Pharm Pharmacol 23:288–94
   PubMedGoogle Scholar
• Beckett AH, Navas GE. (1976). Some oxidation products of 2-substituted phenothiazines. J Pharm Pharmacol 28(Suppl.):16P
   Google Scholar
• Beckett AH, Navas GE. (1978). Aromatic oxidation of some phenothiazines. Xenobiotica 8:721–36
   PubMed Web of Science ®Google Scholar
• Beckett AH, Al-Sarraj S, Essien EE. (1975). The metabolism of chlorpromazine and promethazine to give new ‘pink spots’. Xenobiotica 5:325–55
   PubMed Web of Science ®Google Scholar
• Bernardi L, Coda S, Nicolella V, et al. (1979). Radioisotopic and synthetic studies related to caroxazone metabolism in man. Arzneim Forsch 29:1412–16
   PubMedGoogle Scholar
• Bernthsen A. (1883). Zur Kenntniss des Methylenblau und verrwander Farstoffe. Ber Deut Chem Ges 16:2896–904
   Google Scholar
• Bernthsen A. (1885). Studien in der Methylenblau-gruppe. Justus Liebigs Ann Chem 230:73–211
   Google Scholar
• Berté F, Benzi G. (1967). The tissue distribution and metabolism of amidopyrine in the rat and pregnant and non-pregnant rabbit. J Pharm Pharmacol 19:608–11
   PubMedGoogle Scholar
• Betti M. (1907). Spontaneous oxidation in presence of benzaldehyde. Gazz Chim Ital 36:427–33
   Google Scholar
• Beyer KH, Ruch-Zaske G. (1986). Rubazonsäure – ein Artefakt? Pharm Ztg 131:2307–9
   Google Scholar
• Bray GA. (1993). Use and abuse of appetite-suppressant drugs in the treatment of obesity. Ann Intern Med 119:707–13
   PubMed Web of Science ®Google Scholar
• Brito-Babapulle LAP. (1946). Phenothiazine and the elephant caecal worms. Vet J 102:368
   Google Scholar
• Brodie BB, Axelrod J. (1950). The fate of aminopyrine (Pyramidon) in man and methods for the estimation of aminopyrine and its metabolites in biological material. J Pharmacol Exp Ther 99:171–84
   PubMed Web of Science ®Google Scholar
• Brofman BL, Hellerstein HK, Caskey WH. (1952). Mephentermine: an effective pressor amine; clinical and laboratory observations. Am Heart J 44:396–406
   PubMedGoogle Scholar
• Caldwell J. (1980). Comparative aspects of detoxication in mammals. In: Jakoby WB, ed. Enzymatic basis of detoxication. Vol. 1. New York: Academic Press, 85–114
   Google Scholar
• Caldwell J. (1982). Conjugation reactions of nitrogen centres. In: Jakoby WB, Bend JR, Caldwell J, eds. Metabolic basis of detoxication; metabolism and functional groups. New York: Academic Press, 291–306
   Google Scholar
• Caldwell J. (1985). Novel xenobiotic-lipid conjugates. Biochem Soc Trans 13:852–4
   PubMedGoogle Scholar
• Caldwell J, Marsh MV. (1983). Interrelationships between xenobiotic metabolism and lipid biosynthesis. Biochem Pharmacol 32:1667–72
   PubMed Web of Science ®Google Scholar
• Caldwell J, Köster U, Smith RL, Williams RT. (1975). Species variations in the N-oxidation of chlorphentermine. Biochem Pharmacol 24:2225–32
   PubMed Web of Science ®Google Scholar
• Caldwell J, Michel M, Smith RL. (1977). Metabolic fate in the rat of the N-oxidation products of chlorphentermine. Proc Eur Soc Toxicol (Clin Toxicol) 18:241–2
   Google Scholar
• Campbell FL, Sullivan WN, Smith LE, Haller HL. (1934). Insecticidal tests of synthetic organic compounds – chiefly tests of sulphur compounds against culicine mosquito larvae. J Econ Entomol 27:1176–85
   Google Scholar
• Chang MJW, Leighty EG, Fentiman AF. (1986). Acylation of xenobiotic alcohols: A metabolic pathway for drug retention. In: Paulson GD, Caldwell J, Hutson DH, Menn JJ, eds. Xenobiotic conjugation chemistry. Wasington, DC: American Chemical Society, ACS Symposium Series No. 299, 214–20
   Google Scholar
• Cho AK. (1974). The identification of p-hydroxyphentermine as a urinary metabolite of phentermine. Res Commun Chem Pathol Pharmacol 7:67–78
   PubMedGoogle Scholar
• Cho AK, Hodshon BJ, Lindeke B, Jonsson J. (1975). p-Hydroxylation of amphetamine and phentermine by rat liver microsomes. Xenobiotica 5:531–8
   PubMed Web of Science ®Google Scholar
• Cho AK, Lindeke B, Sum CY. (1974). The N-hydroxylation of phentermine (2-methyl-2-amino-1-phenylpropane). Drug Metab Dispos 2:1–8
   PubMed Web of Science ®Google Scholar
• Clare NT. (1947). A photosensitized keratitis in young cattle following the use of phenothiazine as an anthelmintic. II. The metabolism of phenothiazine in ruminants. Aust Vet J 23:340–4
   Google Scholar
• Criegee R. (1936). Osmiumsäure-ester als Zwischenprodukte bei Oxydationen. Ann Chem 522:75–96
   Google Scholar
• Criegee R, Marchand B, Wannowius H. (1942). Zur Kenntnis der organischen Osmium-Verbindungen. II. Mitteilung. Ann Chem 550:99–133
   Google Scholar
• Curtius J. (1912). Über die Reduktion der aromatischen Aldazine. J Prakt Chem 85:37–77
   Google Scholar
• Cymerman-Craig J, Warburton WK. (1956). Lipoid-water partition coefficients of some phenothiazines. Aust J Chem 9:294–5
   Google Scholar
• Dakin HD. (1922). Oxidations and reductions in the animal body. London: Longman, Green and Co., 64 p
   Google Scholar
• Davey DG, Innes JRM. (1942). The present position of phenothiazine as an amthelmintic: Rev Vet Bull (Commonwealth Bureau of Animal Health) 12:7–14
   Google Scholar
• Delbressine LPC, Funke CW, van Tilborg M, Kaspersen FM. (1990). On the formation of carbamate glucuronides. Xenobiotica 20:133–4
   PubMed Web of Science ®Google Scholar
• Dobryina VI. (1963). Absorption, distribution, conversion, and excretion of phenothiazine in sheep. Materialy 8-oi [Vos'moi] Nauchnii Konferentsia po Farmakologii (Moscow) Shornik, 78–80: Zhurnal Biologii i Khimii 21F851; Chem Abstr (1964) 60:13774b
   Google Scholar
• Drechsel E. (1877). Ueber Einige neue carbaminsäure Salze. J Prakt Chem 16:180–200
   Google Scholar
• Dubnick B, Towne CA, Hartigan JM, Phillips GE. (1968). The distribution and metabolism of chlorphentermine-14C in rats and mice. Biochem Pharmacol 17:1243–50
   PubMed Web of Science ®Google Scholar
• Duffin GF, Kendall JD. (1955). The isomerization of 2,3-bis(arylhydrazone)-γ-butyrolactones. J Chem Soc 3969–71
   Google Scholar
• Duncan JD, Cho AK. (1982). N-oxidation of phentermine to N-hydroxyphentermine by a reconstituted cytochrome P-450 oxidase system from rabbit liver. Mol Pharmacol 22:235–8
   PubMed Web of Science ®Google Scholar
• Eckfeld DK, Abell LL, Seifter J. (1954). Pharmacological properties of mephentermine, a sympathomimetic amine. J Am Pharm Assoc (Baltim) 43:705–8
   PubMedGoogle Scholar
• Efremov GK. (1949). Use of phenothiazine against parascariasis in bears. Moscova Veterinariya 26:4; Helminthol Abstr 18:281q
   Google Scholar
• Eling TE, Mason RP, Sivarajah K. (1985). The formation of aminopyrine cation radical by the peroxidase activity of prostaglandin H synthase and subsequent reactions of the radical. J Biol Chem 260:1601–7
   PubMed Web of Science ®Google Scholar
• Elvin AT, Kennaghan JB, Bynes EW, et al. (1980a). Tocainide conjugation in humans: novel biotransformation pathway for a primary amine. J Pharm Sci 69:47–9
   PubMed Web of Science ®Google Scholar
• Elvin AT, lalka D, Stoeckel K, et al. (1980b). Tocainide kinetics and metabolism: effects of phenobarbital and substrates of glucuronyl transferase. Clin Pharmacol Ther 28:652–8
   PubMed Web of Science ®Google Scholar
• Esserman HB. (1952). The mode of action of phenothiazine as an anthelmintic. II. Phenothiazine in the intestinal fluid and nematode parasites of treated animals. Aust J Sci Res, Ser B (Biol Sci) 5:485–95
   Google Scholar
• Everson E, Beegle LC. (1943). The condensation of aminoantipyrine. III. The synthesis of methylrubazonic acid. J Org Chem 8:429–32
   Google Scholar
• Fleischmann L. (1973). Aminopyrin-resorption und –Stoffwechsel nach rektaler Verabreichung beim Menschen. Pharm Acta Helv 48:192–9
   PubMedGoogle Scholar
• Flury F, Wieland H. (1921). War gas poisoning. VII. The pharmacological action of dichloroethylsulfide. Zeit Ges Expt Med 13:367–483
   Google Scholar
• Folse DS. (1961). Phenothiazine:an annotated bibliography 1934-1958. Kansas Agr Exp Sta, Tech Bull 115:1–216
   Google Scholar
• Freri M. (1936). Transformation products of some hydrazides of organic acids. III. Gazz Chim Ital 66:23–30
   Google Scholar
• Garcia LC, Ramos-Levi A, Lopera CM, Herrera MAR. (2013). Update on pharmacology of obesity: Benefits and risks. Nutricion Hospitalaria 28:121–7
   PubMedGoogle Scholar
• Gillette JR, Dingwell JV, Brodie BB. (1958). Dealkylation of N-alkylamines by model systems. Nature 181:898–9
   PubMedGoogle Scholar
• Gipple KJ, Chan KT, Elvin AT, et al. (1982). Species differences in the urinary excretion of the novel primary amine conjugate: tocainide carbamoyl-O-beta-D-glucuronide. J Pharm Sci 71:1011–14
   PubMedGoogle Scholar
• Gradnick B. (1968). Metabolic transformations of 4-(dimethylamino)antipyrine (amidopyrine). Boll – Soc Ital Biol Sper 44:1564–8
   PubMedGoogle Scholar
• Gradnick R, Fleischmann L. (1973). Quantitative urinary excretion of various aminopyrine metabolites in man. Pharm Acta Helv 48:181–91
   PubMedGoogle Scholar
• Griffin BW, Ting PL. (1978). Mechanism of N-demethylation of aminopyrine by hydrogen peroxide catalysed by horseradish peroxidase, metmyoglobin and protohemin. Biochemistry 17:2205–11
   Google Scholar
• Guengerich FP. (2001a). Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chem Res Toxicol 14:611–50
   PubMed Web of Science ®Google Scholar
• Guengerich FP. (2001b). Uncommon P450-catalysed reactions. Curr Drug Metab 2:93–115
   PubMed Web of Science ®Google Scholar
• Gylys JA, Hart JJ, Warren MR. (1962). Chlorphentermine, a new anorectic agent. J Pharmacol Exp Ther 137:365–73
   PubMed Web of Science ®Google Scholar
• Gysling H, Schwarzenbach G. (1949). Metallindikatoren. II. Beziehungen zwischen Struktur und Komplexbildungsvermögen bei Verwandten des Murexids. Helv Chim Acta 32:1484–504
   Google Scholar
• Halberkann J, Fretwurst F. (1950). Die Stoffwechselprodukte des Pyramidons und verwandter Verbindungen beim Menschen. Hoppe-Seyler's Z Physiol Chem 285:97–127
   PubMedGoogle Scholar
• Hansel W, Friedmann KH. (1983). Rubazonsäure – Metabolit oder Artefakt? Deutsche Apotheker Zeitung 44:2143–7
   Google Scholar
• Harding TS. (1946). Phenothiazine story. Med Rec 159:454–56
   Google Scholar
• Hathway DE. (1970). Biotransformations. In: Hathway DE ed. Foreign compound metabolism in mammals. Vol. 1. London: The Chemical Society, 144–5
   Google Scholar
• Hayakawa H, Fukushima Y, Kato H, et al. (2003). Metabolism and disposition of novel des-fluoro quinolone garenoxacin in experimental animals and an interspecies scaling of pharmacokinetic parameters. Drug Metab Dispos 31:1409–18
   PubMed Web of Science ®Google Scholar
• Hinsvark ON, Truant DJ, Jenden DJ, Steinborn JA. (1973). The oral bioavailability and pharmacokinetics of soluble and resin-bound forms of amphetamine and phentermine in man. J Pharm Biopharm 1:319–28
   Google Scholar
• Imaoka S, Inoue K, Funae Y. (1988). Aminopyrine metabolism by multiple forms of cytochrome P-450 from rat liver microsomes: simultaneous quantitation of four aminopyrine metabolites by high-performance liquid chromatography. Arch Biochem Biophys 265:159–70
   PubMed Web of Science ®Google Scholar
• Jacobs RD, Hogsette JA, Butcher GD. (2003). Nematode parasites in poultry (and where to find them). Dairy and Poultry Science Department, Florida Cooperative Extension Service, Institute of Food and Agricultural Sciences, University of Florida, Gainesville, FL. Fact Sheet PS–18, 1–3
   Google Scholar
• Jaffe M. (1901). Ueber den nach Pyramidongebrauch im Harn auftretenden rothen Farbstoff. Ber Deut Chem Ges 34:2737–41
   Google Scholar
• Jaffe M. (1902). Antipyrylharnstoff, ein Stoffwechselderivat des Pyramidons. Ber Deut Chem Ges 35:2891–5
   Google Scholar
• Jori A, Di Salle E, Quadri A. (1972). Rate of aminopyrine disappearance from plasma in young and aged humans. Pharmacology 8:237–79
   Google Scholar
• Jun HW, Triggs EJ. (1970). Blood levels of chlorphentermine in man. J Pharm Sci 59:306–8
   PubMedGoogle Scholar
• Kadlubar FF, Morton KC, Ziegler DM. (1973). Microsomal-catalysed hydroperoxide-dependent C-oxidation of amines. Biochem Biophys Res Commun 54:1255–61
   PubMed Web of Science ®Google Scholar
• Kelly JD, Whitlock HV, Gunawan M, et al. (1981). Anthelmintic efficacy of low dose phenothiazine against strains of sheep's nematodes susceptible or resistant to thiabendazole, levamisole and morantel tartrate; effect on patent infections. Res Vet Sci 30:161–9
   PubMedGoogle Scholar
• Khan AA, Riemersma JC, Booij HL. (1961). The reactions of osmium tetroxide with lipids and other compounds. J Histochem Cytochem 9:560–3
   PubMedGoogle Scholar
• Kiep L, Maderner S, Seifert K. (2002). Metabolism of metamizol in early stages of the incubated hen's egg. Pharmazie 57:829–33
   PubMed Web of Science ®Google Scholar
• Knipling EF. (1938). Intestinal treatment of animals with phenothiazine to prevent development of horn fly larvae in the manure. J Econ Entomol 27:315–16
   Google Scholar
• Knorr L. (1887). Synthetische Versuche mit dem Acetessigester. Justus Liebigs Ann Chem 238:137–219
   Google Scholar
• Koester U, Caldwell J, Smith RL. (1974). Species variation in the N-oxidation of chlorphentermine. Biochem Soc Trans 2:881–2
   Google Scholar
• Kolzumi T, Ueda M, Takada S. (1974). Urine data analysis for pharmacokinetics of aminopyrine and its metabolites in man. Chem Pharm Bull 22:894–906
   PubMedGoogle Scholar
• Korn ED. (1967). A chromatographic and spectrophotometric study of the products of the reaction of osmium tetroxide with unsaturated lipids. J Cell Biol 34:627–38
   PubMed Web of Science ®Google Scholar
• Kryukova LM, Ioffe IS, Kim LY. (1973). Phenylmethyldioxopyrazoline derivatives. V. Structure of rubazonic acid. Zh Org Khim 9:1262–5
   Google Scholar
• Kushner RF. (2014). Weight loss strategies for treatment of obesity. Prog Cardiovasc Dis 56:465–72
   PubMed Web of Science ®Google Scholar
• Kwok DW, Pillai G, Vaughan R, et al. (1990). Preparative high-performance liquid chromatography and preparative thin-layer chromatography isolation of tocainide carbamoyl-O-beta-D-glucuronide: structural characterization by gas-chromatography-mass spectrometry and fast atom bombardment mass-spectrometry. J Pharm Sci 79:857–61
   PubMed Web of Science ®Google Scholar
• Lasker JM, Sivarajah K, Mason R, et al. (1981). A free radical mechanism of prostaglandin synthase-dependent aminopyrine demethylation. J Biol Chem 256:7764–7
   PubMed Web of Science ®Google Scholar
• Leighty EG, Fentiman AF. (1983). Fatty acid conjugation with cyclamate metabolites as a possible mechanism for ultimate selection. Food Chem Toxicol 21:251–4
   PubMed Web of Science ®Google Scholar
• Leo A, Hansch C, Elkins D. (1971). Partition coefficients and their uses. Chem Rev 71:525–616
   Web of Science ®Google Scholar
• Leuchs H. (1906). Ueber die Glycin-carbonsäure. Ber Deut Chem Ges 39:857–61
   Google Scholar
• Lin C, Puar MS, Schuessler D, et al. (1984). Isolation and identification of a metabolite of rosaramicin in human urine. Drug Metab Dispos 12:51–6
   PubMedGoogle Scholar
• Lippich F. (1908). Über Uramidosäuren. Ber Deut Chem Ges 41, 2953–83
   Google Scholar
• Lyons ET, Drudge JH, Tolliver SC, Stamper S. (1993). Controlled tests of activity of several antiparasitic compounds against natural infections of Haemonchus contortus and other helminths in lambs from a flock established in 1962. Am J Vet Res 54:406–10
   PubMedGoogle Scholar
• Manson-Bahr P. (1940). Phenothiazine as an anthelmintic in threadworm and roundworm infections. Lancet 239:808–9
   Google Scholar
• Mashford PM, Jones AR. (1982). Formaldehyde metabolism by the rat: a re-appraisal. Xenobiotica 12:119–24
   PubMed Web of Science ®Google Scholar
• Metwally MA, Bondock SA, El-Desouky SI, Abdou MM. (2012). Pyrazol-5-ones: tautomerism, synthesis and reactions. Int J Modern Org Chem 1:19–54
   Google Scholar
• Michel-Lipowsky M, Caldwell J, Smith RL. (1977). The reversibility of the N-oxidation products of chlorphnetermine. Biochem Soc Trans 5:1005–6
   PubMedGoogle Scholar
• Mitchell SC. (1982). Mammalian metabolism of orally administered phenothiazine. Drug Metab Rev 13:319–43
   PubMed Web of Science ®Google Scholar
• Mitchell SC. (1994). The toxicity of phenothiazine. Drug Metab Drug Interact 11:201–35
   PubMedGoogle Scholar
• Mitchell SC. (2006). Phenothiazine: the parent molecule. Curr Drug Targets 7:1181–9
   PubMed Web of Science ®Google Scholar
• Mitchell SC, Kestell P, Steventon GB, Waring RH. (2002). Fate of the anthelmintic, phenothiazine, in man. Xenobiotica 32:771–82
   PubMed Web of Science ®Google Scholar
• Mitchell S, Steventon G, Waring R. (2009). Metabolic fate of phenothiazine in the marmoset (Callithrix jacchus). Drug Metab Drug Interact 24:137–51
   PubMedGoogle Scholar
• Mitchell SC, Waring RH. (1979). Metabolism of phenothiazine in the guinea pig. Drug Metab Dispos 7:399–403
   PubMed Web of Science ®Google Scholar
• Mori MA, Kobayashi M, Uemura H, et al. (1992). Intestinal metabolism of mephentermine and its biliary metabolites in male Wistar rats. Xenobiotica 22:701–8
   PubMed Web of Science ®Google Scholar
• Mori MA, Kobayashi M, Yumoto Y, et al. (1991). Metabolism of mephentermine in male guinea pig and male mice. Xenobiotica 21:1301–9
   PubMed Web of Science ®Google Scholar
• Mori MA, Uemura H, Kobayashi M, et al. (1993). Metabolism of phentermine and its derivatives in the male Wistar rat. Xenobiotica 23:709–16
   PubMed Web of Science ®Google Scholar
• Mori M, Uy-Yu N, Sakai K, et al. (1989). Urinary and biliary metabolites of mephentermine in male Wistar rats. Xenobiotica 19:287–99
   PubMed Web of Science ®Google Scholar
• Mori M, Uy-Yu N, Sakai K, et al. (1990). Isolation of urinary p-hydroxylated metabolites of mephentermine and phentermine in male Wistar rats. Xenobiotica 20:653–6
   PubMed Web of Science ®Google Scholar
• Muecke W. (1983). Separation and purification of pesticide metabolites. In: Hutson DH, Roberts TR, eds. Progress in pesticide biochemistry and toxicology. Vol. 3. Chichester: Wiley, 279–366
   Google Scholar
• Mueller B, Noeschel H. (1975). Effect of pregnancy on the biotransformation of aminophenazone. Zentralbl Gynaekol 97:601–4
   PubMedGoogle Scholar
• Naito S, Ueno Y, Yamaguchi H, Nakai T. (1971). Biopharmaceutical studies on 4-(aminoethanesulfonylamino)antipyrine and related compounds. J Pharm Sci 60:245–9
   PubMedGoogle Scholar
• Nelson JW. (1961). Lubricant containing a fatty acid amide of phenothiazine. US Patent 2,998,386 (Assignee; Sinclair Refining Co., New York, NY, USA) Publication date 29 Aug 1961, Filing date 26 Jan 1959, 4 p
   Google Scholar
• Obach RS, Reed-Hagan AE, Krueger SS, et al. (2006). Metabolism and disposition of varenicline, a selective α4β2 acetylcholine receptor partial agonist, in vivo and in vitro. Drug Metab Dispos 34:121–30
   PubMed Web of Science ®Google Scholar
• O'Donnell JP. (1982). The reaction of amines with carbonyls: its significance in the nonenzymatic metabolism of xenobiotics. Drug Metab Rev 13:123–59
   PubMed Web of Science ®Google Scholar
• Opitz K, Weischer ML. (1966). Die Ausscheidung von anorektischen Phenylalkylamine im Urin. Arzneim Forsch 16:1311–13
   PubMedGoogle Scholar
• Perez-Gilabert M, Sanchez-Ferrer A, Garcia-Carmona F. (1997). Oxidation of aminopyrine by the hydroperoxidase activity of lipoxygenase: a new proposed mechanism of N-demethylation. Free Radic Biol Med 23:548–55
   PubMed Web of Science ®Google Scholar
• Petchtold F. (1964). Die methylrubazonsäure als oxydationsprodukt von derivaten des 4-aminophenazons. Arzneim-Forsch 14:474–5
   PubMedGoogle Scholar
• Preuss FR, Voigt KM. (1964). Zum Nachwels von Methylrubazonsäure nach Gabe von Dimethylaminophenyldimethylpyrazolon beim Menschen. Naturwissenschaften 51:537–8
   Google Scholar
• Preuss FR, Voigt KM. (1965). Über die Vorstufen die Bildung der Methylrubazonsaure nach Einnahme von Amidopyrin. Arneim-Forsch 15:741–7
   PubMed Web of Science ®Google Scholar
• Pröscher F. (1902). Ueber eine neue Synthese der Methylrubazonsäure. Ber Deut Chem Ges 35:1436–7
   Google Scholar
• Quistad GB. (1986). Novel polar xenobiotic conjugates. In: Paulson GD, Caldwell J, Hutson DH, Menn JJ, eds. Xenobiotic conjugation chemistry. Washington, DC: American Chemical Society, ACS Symposium Series No. 299, 221–41
   Google Scholar
• Quistad GB, Hutson DH. (1986). Lipophilic xenobiotic conjugates. In: Paulson GD, Caldwell J, Hutson DH, Menn JJ, eds. Xenobiotic conjugation chemistry. Washington, DC: American Chemical Society, ACS Symposium Series No. 299, 204–13
   Google Scholar
• Riemersma JC. (1963). Osmium tetroxide fixation of lipids: nature of the reaction products. J Histochem Cytochem 11:436–42
   Web of Science ®Google Scholar
• Riemersma JC. (1968). Osmium tetroxide fixation of lipids for electron microscopy: a possible reaction mechanism. Biochem Biophys Acta 152:718–27
   PubMed Web of Science ®Google Scholar
• Rodd EH. (1957). The chemistry of carbon compounds. Vol. 4. London: Elsevier Publishing Co., 269–70
   Google Scholar
• Ruch-Zaske G. (1985). Untersuchungen zur Analytik, Biotransformation, Entzündungspharmakologie und Pharmakokinetik des Isopropylaminophenazon (Isopyrin©) unter vergleichender Berücksichtigung anderer ausgewählter Pyrazolinoderivative. Doctoral Dissertation. Faculty of Pharmacy, University of Berlin. Freie Universität Berlin, 1–151
   Google Scholar
• Salkowski E. (1872). Ueber die Bildung der Schwefelsäure und des Harnstoffs und das Verhalten des Taurins im Thierkörper. Ber Deut Chem Ges 5:637–9
   Google Scholar
• Salkowski E. (1873). Ueber die Entstehung der Schwefelsäure und das Verhalten des Taurins im thierischen Organismus. Virchow's Arch Pathol Anat Physiol 58:460–508
   Google Scholar
• Salkowski E. (1882). Weitere Beiträge zur Kenntniss der Harnstoffbildung. Das Verhalten der Amidobenzoësäure im Thierkörper. Hoppe-Seyler's Z Physiol Chem 7:93–113
   Google Scholar
• Sartori M. (1939). The war gases. Chemistry and analysis. (translated from Italian by Marrison LW). New York: Van Nostrand Co. Inc., 214–53
   Google Scholar
• Schmidt CLA, Allen EG. (1920). Further studies on the elimination of taurine administered to man. J Biol Chem 42:55–8
   Google Scholar
• Schüppel R, Soehring K. (1965). Quantitative Untersuchungen über den Amidopyrin-Stoffwechsel beim Menschen. Pharm Acta Helv 40:105–24
   PubMedGoogle Scholar
• Senda C, Toda S, Tateishi M, et al. (2003). Mexiletine carbonyloxy β-D-glucuronide: a novel metabolite in human urine. Xenobiotica 33:871–84
   PubMed Web of Science ®Google Scholar
• Shelton RS, Van Campen Jr MG. (1946). Vasopressor amine: Composition of matter and method. US patent 2,408,345 (24th Sept 1946) Assignee: the William S Merrell Chemical Company, Cincinnati, OH, 3 p
   Google Scholar
• Shyh G, Cheng-Lai A. (2014). New antiobesity agents: lorcaserin (Belviq) and phentermine/topiramate ER (Qsymia). Cardiol Rev 22:43–50
   PubMedGoogle Scholar
• Siegfried M. (1906). Ueber die Abscheidung von Amidosäuren. Ber Deut Chem Ges 39:397–401
   Google Scholar
• Silverstone T. (1992). Appetite suppressants. A review. Drugs 43:820–36
   Google Scholar
• Sisenwine SF, Tio CO, Shrader SR, Ruelius HW. (1972). The biotransformation of oxazepam (7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one) in man, miniature swine and rat. Arzneim Forsch 22:682–7
   PubMed Web of Science ®Google Scholar
• Smith LE, Munger F, Siegler EH. (1935). Phenothiazine, a promising new insecticide. J Econ Entomol 28:727–8
   Google Scholar
• Smith GM, Parsons ME, Whitehouse MW. (1964). Biochemical and pharmacological properties of some amidopyrine metabolites. J Pharm Pharmacol 16:830–1
   PubMed Web of Science ®Google Scholar
• Steward JS. (1950). Trichostrongylosis and haemonchosis in the camel: their recognition and response to phenothiazine. Vet Rec 62:837–9
   PubMedGoogle Scholar
• Sum CY, Cho AK. (1977). The N-hydroxylation of phentermine by rat liver microsomes. Drug Metab Dispos 5:464–8
   PubMed Web of Science ®Google Scholar
• Sum CY, Cho AK. (1979). The metabolism of N-hydroxyphentermine by rat liver microsomes. Drug Metab Dispos 7:65–9
   PubMed Web of Science ®Google Scholar
• Sundukov AI. (1963). Absorption, secretion, and distribution of phenothiazine in calves. Materialy 8-oi [Vos'moi] Nauchnii Konferentsia po Farmakologii (Moscow) Shornik, 80–81; Zhurnal Biologii i Khimii, (1963) 21F850; Chem Abstr (1964) 60:13774c
   Google Scholar
• Tanaka T, Kaneo Y, Goromaru T, Iguchi S. (1987). Further metabolism of 4-acetylaminoantipyrine, the major metabolite of aminopyrine, in rats. Chem Pharm Bull 35:3519–22
   PubMedGoogle Scholar
• Taylor EL, Sanderson KM. (1940). A remarkably efficient anthelmintic. Vet Rec 52:635–47
   Google Scholar
• Testa B, Jenner P. (1976). Drug metabolism: chemical and biochemical aspects. New York: Marcel Dekker Inc., 165–66, 215
   Google Scholar
• Tomankova H, Zyka J. (1975). Oxidation of aminophenazone by hydrogen peroxide. Microchem J 20:132–53
   Google Scholar
• Tong Z, Chandransekaran A, DeMaio W, et al. (2010a). Metabolism of vabicaserin in mice, rats, dogs, monkeys and humans. Drug Metab Dispos 38:2266–77
   PubMed Web of Science ®Google Scholar
• Tong Z, Chandrasekaran A, DeMaio W, et al. (2010b). Species differences in the formation of vabicaserin carbamoyl glucuronide. Drug Metab Dispos 38:581–90
   PubMed Web of Science ®Google Scholar
• Tremaine LM, Stroh JG, Ronfeld RA. (1989). Characterization of a carbamic acid ester glucuronide of the secondary amine, sertraline. Drug Metab Dispos 17:58–63
   PubMed Web of Science ®Google Scholar
• Underhill FP, Closson OE. (1905). The physiological behaviour of methylene blue and methylene azure: a contribution to the study of the oxidation and reduction processes in the animal organism. Am J Physiol 13:358–71
   Google Scholar
• van der Wetering-Krebbers SF, Jacobs PL, Kemperman GJ, et al. (2011). Metabolism and excretion of arsenapine in healthy male subjects. Drug Metab Dispos 39:580–90
   PubMedGoogle Scholar
• Vecerkova J, Vecerek B, Kacl, K. (1966). Use of paper chromatography for toxicological determination of drugs. VII. Paper chromatography of aminophenazone metabolites. Pharmazie 21:682–5
   Google Scholar
• Ville J. (1892). Transformation, dans l'économie, de l'acide sulfanilique en acide sulfanilocarbamique. C R Acad Sci Paris 114:228–31
   Google Scholar
• Volz M, Kellner HM. (1980). Kinetics and metabolism of pyrazolones (propyphenazone, aminopyrine and dipyrone). Br J Clin Pharmacol 10:299S–308S
   Web of Science ®Google Scholar
• Walkenstein SS, Chumakow N, Seifer J. (1955). Detoxication and excretion of mephentermine. J Pharmacol Exp Ther 115:16–20
   PubMed Web of Science ®Google Scholar
• Weischer VML, Opitz K. (1967). Bestimmung von Chlophentermin, Fenfluramin und verwandten Substanzen in Harn. Arzneim Forsch 17:625–7
   PubMedGoogle Scholar
• Wiley RH, Wiley PF. (1964). Chemistry of heterocyclic compounds: pyrazolones, pyrazolidones and derivatives. Vol. 20. London: John Wiley and Sons Ltd, 69–76
   Google Scholar
• Williams RT. (1947). Detoxication mechanisms: the metabolism of drugs and allied organic compounds. London: Chapman and Hall Ltd, 105, 230–1
   Google Scholar
• Williams RT. (1959). Detoxication mechanisms. The metabolism and detoxication of drugs, toxic substances and other organic compounds. 2nd ed. London: Chapman and Hall Ltd, 574–5
   Google Scholar
• Windorfer A Jr, Müller G, Stehr C. (1977). Veränderungen des Aminophenazon-Metabolismus bei akuter Hepatitis in Kindesalter. Deut Med Wschr 102:1460–4
   PubMedGoogle Scholar
• Yalkowsky SH, Dannenfelser RM. (1992). Aquasol database of aqueous solubility. Version 5. College of Pharmacy, University of Arizona, Tucson, AZ
   Google Scholar
• Yang X, Kulkarni AP. (1998). N-Dealkylation of aminopyrine catalysed by soybean lipoxygenase in the presence of hydrogen peroxide. J Biochem Toxicol 12:175–83
   Google Scholar
• Ziegler DM. (1985). Molecular basis for N-oxygenation of sec- and tert-amines. In: Gorrod JW, Damani LA, eds. Biological oxidation of nitrogen in organic molecules: chemistry, toxicology and pharmacology. Chichester: Ellis Horwood Ltd, 43–52
   Google Scholar